Harnessing the Potential Synergistic Interplay Between Photosensitizer Dark Toxicity and Chemotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Harnessing the Potential Synergistic Interplay Between Photosensitizer Dark Toxicity and Chemotherapy
Authors
Keywords
-
Journal
PHOTOCHEMISTRY AND PHOTOBIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-12-20
DOI
10.1111/php.13196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Expression of Yes-Associated Protein (YAP) Maintains Putative Cancer Stemness and Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma
- (2019) Kensuke Sugiura et al. AMERICAN JOURNAL OF PATHOLOGY
- YAP promotes multi-drug resistance and inhibits autophagy-related cell death in hepatocellular carcinoma via the RAC1-ROS-mTOR pathway
- (2019) Yuan Zhou et al. Cancer Cell International
- Predictors and Limitations of the Penetration Depth of Photodynamic Effects in the Rodent Brain
- (2019) Collin T. Inglut et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- Systematic Evaluation of Light-Activatable Biohybrids for Anti-Glioma Photodynamic Therapy
- (2019) Inglut et al. Journal of Clinical Medicine
- Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells
- (2018) Ting Lu et al. BIOMEDICINE & PHARMACOTHERAPY
- Inhibition of the PI3K but not the MEK/ERK pathway sensitizes human glioma cells to alkylating drugs
- (2018) Bodo Haas et al. Cancer Cell International
- Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway
- (2018) Liang Dong et al. International Journal of Medical Sciences
- Current Challenges and Opportunities in Treating Glioblastoma
- (2018) Andrea Shergalis et al. PHARMACOLOGICAL REVIEWS
- Immobilization of Photo-Immunoconjugates on Nanoparticles Leads to Enhanced Light-Activated Biological Effects
- (2018) Huang-Chiao Huang et al. Small
- EGFR-PI3K-PDK1 pathway regulates YAP signaling in hepatocellular carcinoma: the mechanism and its implications in targeted therapy
- (2018) Hongwei Xia et al. Cell Death & Disease
- Verteporfin inhibits papillary thyroid cancer cells proliferation and cell cycle through ERK1/2 signaling pathway
- (2018) Tian Liao et al. Journal of Cancer
- YAP/TAZ Activation as a Target for Treating Metastatic Cancer
- (2018) Janine Warren et al. Cancers
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
- (2018) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Targeting the Hippo Pathway for Breast Cancer Therapy
- (2018) Liqing Wu et al. Cancers
- Verteporfin Inhibits Cell Proliferation and Induces Apoptosis in Human Leukemia NB4 Cells without Light Activation
- (2017) Min Chen et al. International Journal of Medical Sciences
- β-catenin-mediated YAP signaling promotes human glioma growth
- (2017) Yan Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma
- (2017) Wei Xu et al. ONCOLOGY REPORTS
- Verteporfin inhibits growth of human glioma in vitro without light activation
- (2017) Ahmad Al-Moujahed et al. Scientific Reports
- Non-Photoinduced Biological Properties of Verteporfin
- (2016) Floriane Gibault et al. CURRENT MEDICINAL CHEMISTRY
- Far-Red Light-Activatable Prodrug of Paclitaxel for the Combined Effects of Photodynamic Therapy and Site-Specific Paclitaxel Chemotherapy
- (2016) Pritam Thapa et al. JOURNAL OF MEDICINAL CHEMISTRY
- Photonanomedicine: a convergence of photodynamic therapy and nanotechnology
- (2016) Girgis Obaid et al. Nanoscale
- Expression and significance of Hippo/YAP signaling in glioma progression
- (2016) Hao Zhang et al. TUMOR BIOLOGY
- Repurposing platinum-based chemotherapies for multi-modal treatment of glioblastoma
- (2016) Nathan B. Roberts et al. OncoImmunology
- Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer
- (2015) H.-C. Huang et al. CANCER RESEARCH
- The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer
- (2015) S. Song et al. CLINICAL CANCER RESEARCH
- Bcl-2 confers survival in cisplatin treated cervical cancer cells: circumventing cisplatin dose-dependent toxicity and resistance
- (2015) Gina Leisching et al. Journal of Translational Medicine
- Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway
- (2015) U. Ehmer et al. MOLECULAR CANCER RESEARCH
- YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
- (2015) G Hua et al. ONCOGENE
- The role of photodynamic therapy in overcoming cancer drug resistance
- (2015) Bryan Q. Spring et al. PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES
- YAP-Induced Resistance of Cancer Cells to Antitubulin Drugs Is Modulated by a Hippo-Independent Pathway
- (2014) Y. Zhao et al. CANCER RESEARCH
- An Integrative Analysis of the Tumorigenic Role of TAZ in Human Non-Small Cell Lung Cancer
- (2014) S. Noguchi et al. CLINICAL CANCER RESEARCH
- The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation
- (2014) Katarzyna Brodowska et al. EXPERIMENTAL EYE RESEARCH
- Targeting Microtubules by Natural Agents for Cancer Therapy
- (2014) E. Mukhtar et al. MOLECULAR CANCER THERAPEUTICS
- Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates
- (2014) B. Q. Spring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pilot study of intratumoral injection of recombinant heat shock protein 70 in the treatment of malignant brain tumors in children
- (2014) Maxim Shevtsov et al. OncoTargets and Therapy
- Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol
- (2012) Karsten Geletneky et al. BMC CANCER
- An update on targeting Hippo-YAP signaling in liver cancer
- (2012) Angela M Liu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Taxol Resistance in Breast Cancer Cells Is Mediated by the Hippo Pathway Component TAZ and Its Downstream Transcriptional Targets Cyr61 and CTGF
- (2011) D. Lai et al. CANCER RESEARCH
- The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
- (2011) Bin Zhao et al. NATURE CELL BIOLOGY
- Oncogenic EGFR Signaling Activates an mTORC2-NF- B Pathway That Promotes Chemotherapy Resistance
- (2011) K. Tanaka et al. Cancer Discovery
- Synergistic Enhancement of Carboplatin Efficacy with Photodynamic Therapy in a Three-Dimensional Model for Micrometastatic Ovarian Cancer
- (2010) I. Rizvi et al. CANCER RESEARCH
- Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
- (2010) Jonathan P. Celli et al. CHEMICAL REVIEWS
- The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme
- (2010) Klaus Maier-Hauff et al. JOURNAL OF NEURO-ONCOLOGY
- Cisplatin-Resistant Neuroblastoma Cells Express Enhanced Levels of Epidermal Growth Factor Receptor (EGFR) and Are Sensitive to Treatment with EGFR-Specific Toxins
- (2008) M. Michaelis et al. CLINICAL CANCER RESEARCH
- Expression of Yes-associated protein in common solid tumors
- (2008) Angela A. Steinhardt et al. HUMAN PATHOLOGY
- Malignant Gliomas in Adults
- (2008) Patrick Y. Wen et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started